PT Prodia Widyahusada Tbk (IDX:PRDA)

Market Cap	2.20T -3.1%
Revenue (ttm)	2.28T +1.3%
Net Income	206.79B -23.5%
EPS	227.25 -21.2%
Shares Out	889.78M
PE Ratio	10.87
Forward PE	8.63
Dividend	172.93 (7.00%)
Ex-Dividend Date	May 8, 2025

Volume	137,400
Average Volume	632,090
Open	2,470.00
Previous Close	2,470.00
Day's Range	2,470.00 - 2,550.00
52-Week Range	2,290.00 - 3,010.00
Beta	-0.29
RSI	49.56
Earnings Date	Apr 30, 2026

About PT Prodia Widyahusada Tbk

PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pu...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1973
• Employees: 2,908
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PRDA

Financial Performance

In 2025, PT Prodia Widyahusada Tbk's revenue was 2.28 trillion, an increase of 1.31% compared to the previous year's 2.25 trillion. Earnings were 206.79 billion, a decrease of -23.47%.